No description availableLilly star weight-loss drug Zepbound faces coverage challenge from CVS HealthRead full article: Lilly star weight-loss drug Zepbound faces coverage challenge from CVS HealthEli Lilly’s stock wobbled Thursday after a looming coverage hit was detailed for its blockbuster weight-loss drug Zepbound.
